Norlevo (Levonorgestrel)

Levonorgestrel, the active ingredient in Norlevo, is a progestin presented as an oral tablet for oral use. It is used as emergency contraception to prevent pregnancy after unprotected sexual intercourse. GNH USA supplies Norlevo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norlevo, a progestin emergency contraceptive, works within the reproductive hormone pathway to prevent unintended pregnancy. - Emergency contraception (up to 72 hours after unprotected intercourse): reduces the risk of pregnancy when taken promptly. - Emergency contraception (up to 120 hours after unprotected intercourse): provides a later window for effective pregnancy prevention. - Post‑coital contraception: administered as a single dose to inhibit fertilisation after intercourse.

Adverse reactions may occur with oral levonorgestrel emergency contraception.

Common Side Effects: - Nausea - Abdominal pain or cramps - Fatigue or tiredness - Headache - Dizziness - Menstrual irregularities (early, delayed, or heavier bleeding)

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis - Severe abdominal pain or persistent vomiting - Unusual vaginal bleeding or spotting - Chest pain or shortness of breath - Thromboembolic events (deep‑vein thrombosis, pulmonary embolism) - Liver function abnormalities

Before using Norlevo, consider the following safety points. - Timing of administration: take as soon as possible after unprotected intercourse for maximum effectiveness. - Contraindications: do not use if known hypersensitivity to levonorgestrel or any tablet excipients. - Medical conditions: avoid if you have active liver disease, hormone‑dependent tumours, or unexplained vaginal bleeding. - Drug interactions: be aware of medications that may reduce efficacy, such as enzyme‑inducing agents. - Breastfeeding: consult a healthcare professional, as levonorgestrel passes into breast milk in small amounts. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levonorgestrel may interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Rifampicin: induces metabolism and reduces contraceptive effectiveness. - Anticonvulsants (phenytoin, carbamazepine): lower plasma levonorgestrel levels. - St. John’s wort: may decrease drug exposure, compromising emergency contraception.

Moderate Interactions (Monitor Closely): - Hormonal contraceptives: concurrent use may reduce overall contraceptive reliability. - Antifungal azoles (ketoconazole): can increase levonorgestrel concentrations, raising side‑effect risk. - Protease inhibitor antiretrovirals: may alter levonorgestrel metabolism, requiring clinical monitoring.